Dosage regimen for a pi-3 kinase inhibitor

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

CRISTIAN MASSACESI,SAMIT HIRAWAT

申请号：

BR112014028420

公开号：

BR112014028420A2

申请日:

2013.05.14

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The present invention relates to a dosage regimen for a phosphatidylinositol 3-kinase (PI3K) inhibitor compound of formula (I) or a pharmaceutically acceptable salt thereof. More specifically, the present invention relates to a dosage regimen for the treatment of patients suffering from a proliferative disease, such as, for example, cancer, with a phosphatidylinositol 3-kinase (PI3K) inhibitor compound of formula (I) or a pharmaceutically acceptable salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/